(Q98681721)
Statements
A phase III randomized controlled trial to determine safety, efficacy, and immunogenicity of the non-replicating ChAdOx1 nCoV-19 vaccine (English)
0 references
1 May 2020
0 references
31 October 2021
0 references
11 June 2020
0 references
2,000
0 references